Company Profile

ActivSignal LLC
Profile last edited on: 7/18/19      CAGE: 7XHV2      UEI: XK3QGNFL2DE4

Business Identifier: Novel insights into signaling pathway activation
Year Founded
2017
First Award
2019
Latest Award
2021
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

27 Strathmore Road
Natick, MA 01760
   (617) 592-6686
   N/A
   www.activsignal.com
Location: Single
Congr. District: 05
County: Middlesex

Public Profile

ActivSignal LLC is structured around transforming technology into systems biology proteomics tools. For researchers working in the biotech space, the firm is offering a proprietary technology inexpensively providing novel insights into signaling pathway activation. The firm's lead product is the IPAD assay (Immuno-Paired-Antibody Detection assay): research tool for analyzing the activity of multiple signaling pathways in one reaction. Developed to enable researchers to understand the pathway activation / inhibition profile of cells, activities of multiple signaling pathways are assessed simultaneously in a single well through the measurement of 70 target human proteins for modifications, cleavage and expression. Each pathway is covered by multiple targets: easily scalable to 96-well format; highly sensitive, requiring small amount of sample for assay.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2021 2 NSF $1,624,998
Project Title: ActivSignal Protein Profiling from Serum Exosomes for the Early Detection of Pancreatic Cancer

Key People / Management

  Ilya Alexandrov

  Robert Glazer

  Malcolm Mackenzie

Company News

There are no news available.